The global alliance for rare diseases
Rare Diseases International (rarediseasesinternational.org) scores 67 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, Non-profit brands, in the 15th percentile of 13165 Healthcare brands.
Rare Diseases International is a global non-profit alliance representing persons living with rare diseases and their families. It advocates for improved access to care and treatment, sustainable financing, and policy prioritization for rare diseases on an international scale. The organization positions itself as the leading global voice for the rare disease community, engaging patient advocacy organizations, policymakers, and healthcare stakeholders worldwide to drive systemic improvements in rare disease care and policy.
| Brand Name | Rare Diseases International |
|---|---|
| Domain | rarediseasesinternational.org |
| Industry | Healthcare, Non-profit |
| Main Competitors | EURORDIS (80/100), National Organization for Rare Disorders (NORD) (86/100), Global Genes (81/100), EveryLife Foundation for Rare Diseases, International Rare Diseases Research Consortium (IRDiRC) |
Moz Domain Authority 42/100 vs category average 41 / leader 97 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,315,812 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Rare Diseases International is the global alliance of Persons Living with a Rare Disease and their families." (Meta description: 17 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: WordPress, Ghost.
Social footprint: verified profiles on Instagram; no detected presence on X (Twitter), LinkedIn, Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Rare Diseases International?", Claude could identify the brand as of October 2026. Rare Diseases International is a global alliance uniting rare disease patient organizations and networks to advocate for the rights and needs of people living with rare diseases, particularly through engagement with the United Nations and international health policy bodies. Best known for Leading global advocacy for rare disease patients at the United Nations, including efforts around the UN Resolution on persons living with a rare disease.
When asked "Best brands similar to Rare Diseases International?", Claude would recommend Rare Diseases International as of October 2026. It's a genuinely recognized and significant international advocacy body in the rare disease space, so it would be relevant to mention alongside similar patient advocacy organizations.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Rare Diseases International's main competitors in Healthcare: EURORDIS (80/100), National Organization for Rare Disorders (NORD) (86/100), Global Genes (81/100).
Sources: Brand Analyzer scan
Rare Diseases International is a global alliance representing persons living with a rare disease and their families. It functions as a non-profit advocacy organization operating in the healthcare sector, uniting patients, families, advocacy groups, and policymakers to address the challenges faced by the rare disease community worldwide.
Rare Diseases International has limited AI-search visibility, scoring 26/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 49, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Rare Diseases International scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Rare Diseases International can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Rare Diseases International offers advocacy services aimed at improving policy, financing, and access to treatment for rare disease patients. It serves as a platform connecting persons living with rare diseases, their families, and advocacy organizations with policymakers and healthcare stakeholders to drive systemic change rather than offering commercial products.
Rare Diseases International is used by persons living with rare diseases, their families, patient advocacy organizations, policymakers, and healthcare stakeholders globally who seek to collaborate on improving rare disease policy, funding, and access to care.
Rare Diseases International is known for being the only global alliance representing persons living with rare diseases and their families at an international level, advocating for policy prioritization, sustainable financing, and improved access to treatment and care for this community.
Rare Diseases International scores 26/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Rare Diseases International has a weak AI-visibility profile at 26/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is trust (49/100) and its weakest is visibility (0/100). It benefits from a global traffic rank of #1,315,812 (Tranco), a Moz Domain Authority of 42/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Rare Diseases International from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Rare Diseases International: Radiology Partners (67/100), Quro Medical (67/100), The Royal College of Ophthalmologists (67/100), Royal College of Physicians of Edinburgh (67/100).
A step up - brands to learn from: ZT Corporate (71/100), Zorgnet-Icuro (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.